Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle-like structures

Neurobiology of Disease

Volumn 31, Issue 3, 2008, Pages 368-377

  Rankin, Carolyn A ^a   Sun, Qian ^a   Gamblin, T Chris ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Alzheimer's disease; GSK 3 ; Hyperphosphorylation; Neurofibrillary tangle; Phosphorylation; Polymerization; Tau

Indexed keywords

ARACHIDONIC ACID; EPITOPE; GLYCOGEN SYNTHASE KINASE 3BETA; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CELL FREE SYSTEM; IN VITRO STUDY; MICROSCOPY; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN POLYMERIZATION;

ALZHEIMER DISEASE; BRAIN; CATALYTIC DOMAIN; CELL-FREE SYSTEM; EPITOPES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MODELS, BIOLOGICAL; NEUROFIBRILLARY TANGLES; NEURONS; PHOSPHORYLATION; POLYMERS; PROTEIN BINDING; TAU PROTEINS;

EID: 49349110485     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.05.011     Document Type: Article

References (37)

1. Abraha A., et al. C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J. Cell Sci. 113 Pt 21 (2000) 3737-3745
2. Balaraman Y., et al. Glycogen synthase kinase 3beta and Alzheimer's disease: pathophysiological and therapeutic significance. Cell. Mol. Life Sci. 63 (2006) 1226-1235
3. Bancher C., et al. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 477 (1989) 90-99
4. Barghorn S., and Mandelkow E. Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. Biochemistry 41 (2002) 14885-14896
5. Berry R.W., et al. Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment. Biochemistry 42 (2003) 8325-8331
6. Biernat J., et al. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J. 11 (1992) 1593-1597
7. Braak E., et al. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. (Berl.) 87 (1994) 554-567
8. Braak, H., 1996. Evolution of Alzheimer's disease related intraneuronal changes. Fifth International Conference: On Alzheimer's Disease and Related Disorders, Osaka, Japan.
9. Buee L., et al. Tau protein isoforms, phosphorylation and the role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33 (2000) 95-130
10. Carlson S.W., et al. A complex mechanism for inducer mediated tau polymerization. Biochemistry 46 (2007) 8838-8849
11. Chirita C.N., et al. Anionic micelles and vesicles induce tau fibrillization in vitro. J. Biol. Chem. 278 (2003) 25644-25650
12. DeTure M., et al. Evidence for independent mechanisms and a multiple-hit model of tau assembly. Biochem. Biophys. Res. Commun. 339 (2006) 858-864
13. Engel T., et al. Cooexpression of FTDP-17 tau and GSK-3beta in transgenic mice induce tau polymerization and neurodegeneration. Neurobiol Aging 27 (2006) 1258-1268
14. Farooqui A.A., and Horrocks L.A. Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly. Neuroscientist 12 (2006) 245-260
15. Goedert M., et al. Tau protein in Alzheimer's disease. Biochem. Soc. Trans. 23 (1995) 80-85
16. Goux W.J. The conformations of filamentous and soluble tau associated with Alzheimer paired helical filaments. Biochemistry 41 (2002) 13798-13806
17. Holzer M., et al. Abnormally phosphorylated tau protein in Alzheimer's disease: heterogeneity of individual regional distribution and relationship to clinical severity. Neuroscience 63 (1994) 499-516
18. Illenberger S., et al. The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. Mol. Biol. Cell 9 (1998) 1495-1512
19. Ishiguro K., et al. Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett. 325 (1993) 167-172
20. Jackson G.R., et al. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34 (2002) 509-519
21. King M.E., et al. Ligand-dependent tau filament formation: implications for Alzheimer's disease progression. Biochemistry 38 (1999) 14851-14859
22. King M.E., et al. Differential assembly of human tau isoforms in the presence of arachidonic acid. J. Neurochem. 74 (2000) 1749-1757
23. Ksiezak-Reding H., et al. Tau immunoreactivity and SDS solubility of two populations of paired helical filaments that differ in morphology. Brain Res. 649 (1994) 185-196
24. Lee V.M., et al. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24 (2001) 1121-1159
25. Leroy K., et al. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol. Appl. Neurobiol. 33 (2007) 43-55
26. Liou Y.C., et al. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 424 (2003) 556-561
27. Lu P.J., et al. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399 (1999) 784-788
28. Mercken M., et al. Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol. 84 (1992) 265-272
29. Otvos Jr. L., et al. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J. Neurosci. Res. 39 (1994) 669-673
30. Porzig R., et al. Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein. Biochem. Biophys. Res. Commun. 358 (2007) 644-649
31. Rankin C.A., et al. Pseudo-phosphorylation of tau at Ser202 and Thr205 affects tau filament formation. Brain Res. Mol. Brain Res. 138 (2005) 84-93
32. Rankin C.A., et al. Tau phosphorylation by GSK-3beta promotes tangle-like filament morphology. Mol. Neurodegener. 2 (2007) 12
33. Shimura H., et al. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J. Biol. Chem. 279 (2004) 4869-4876
34. Song J.S., and Yang S.D. Tau protein kinase I/GSK-3 beta/kinase FA in heparin phosphorylates tau on Ser199, Thr231, Ser235, Ser262, Ser369, and Ser400 sites phosphorylated in Alzheimer disease brain. J. Protein Chem. 14 (1995) 95-105
35. Steinhilb M.L., et al. S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila. J. Neurosci. Res. 85 (2007) 1271-1278
36. Stoothoff W.H., and Johnson G.V. Tau phosphorylation: physiological and pathological consequences. Biochim. Biophys. Acta 1739 (2005) 280-297
37. Vincent I., et al. Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiol. Aging 19 (1998) 287-296